Search Results

Value Insider Season 1 Episode 6: How Will Market Access and Value Demonstration Evolve? (Future Outlook) [Podcast]

• Authors : Kanavos, Panos G.; Hartgers-Gubbels, Elisabeth Sophia; Chambers, Michael

• Source: International Journal of General Medicine. December 31, 2022, Vol. 15, p8429, 7 p.

Record details

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.

• Authors : WOUTERS, OLIVIER J.; KANAVOS, PANOS G.; McKEE, MARTIN

• Source: The Milbank Quarterly. 2017, Vol. 95, Issue 3, pages. 48

Record details

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform/Transition vers un nouveau systeme de sante national a Chypre: analyse par les parties prenantes de la reforme des politiques pharmaceutiques/La transicion a un sistema nacional de salud en Chipre: un analisis de los interesados en la reforma de la politica farmaceutica

• Authors : Wouters, Olivier J.; Kanavos, Panos G.

• Source: Bulletin of the World Health Organization. September, 2015, Vol. 93 Issue 9, p606, 8 p.

Record details

Early chronic kidney disease: diagnosis, management and models of care

• Authors : Wouters, Olivier J.; O'Donoghue, Donal J.; Ritchie, James

• Source: Nature Reviews Nephrology. August 1, 2015, p491, 12 p.

Record details

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform/Transition vers un nouveau systeme de sante national a Chypre: analyse par les parties prenantes de la reforme des politiques pharmaceutiques/La transicion a un sistema nacional de salud en Chipre: un analisis de los interesados en la reforma de la politica farmaceutica

• Authors : Wouters, Olivier, J.; Kanavos, Panos, G.

Record details

A comparison of generic drug prices in seven European countries: a methodological analysis.

• Authors : Wouters, Olivier J.; Kanavos, Panos G.

Subjects: DRUG prices; DRUG laws; PRICINGEUROPE

• Source: BMC Health Services Research; 3/31/2017, Vol. 17, p1-7, 7p, 1 Chart, 1 Graph

Record details

How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-α and Darbepoetin-α in 2001–3 and the Cost Implications for CMS.

• Authors : Kanavos, Panos G.; Saka, Ömer R.

Subjects: MEDICAL care costs; HEALTH insurance reimbursement; HEALTH policy

• Source: Disease Management & Health Outcomes; Dec2005, Vol. 13 Issue 6, p359-370, 12p

Record details

Patent Settlements in the Pharmaceutical Industry Under US Antitrust and EU Competition Law

• Authors : Amalia Athanasiadou

Subjects: Drugs--Law and legislation--United States; Patent suits--United States; Pharmacy--Law and legislation--United StatesLAW / Intellectual Property / Patent; LAW / International

Record details

Coalitions and Compliance : The Political Economy of Pharmaceutical Patents in Latin America

• Authors : Kenneth C. Shadlen

Subjects: Pharmaceutical industry--Latin America; Patent laws and legislation--Latin AmericaPOLITICAL SCIENCE / History & Theory

Record details

A comparison of European and US generic drug markets

• Authors : Delahunty, Maysoon

• Source: Generics and Biosimilars Initiative Journal. December 2017, Vol. 6 Issue 4, p190, 3 p.

Record details